| 1. |
- Almroth, Gabriel, 1953-, et al.
(author)
-
Perspectives on hepatitis B infections and the efficacy of vaccination (hepatitis B and pneumococci) in dialysis patients.
- 2003
-
In: Upsala journal of medical sciences. - : Uppsala Medical Society. - 0300-9734 .- 2000-1967. ; 108:1, s. 61-74
-
Journal article (peer-reviewed)abstract
- Hepatitis B is a well known problem in dialysis units. We therefore examined the historical frequency of hepatitis B carriers in our unit, our vaccination program to hepatitis B virus (HBV), the response to hepatitis B vaccine, the IgG subclass response of anti-HBs and the response and IgG subclass response to pneumococcal vaccination (another vaccine) in dialysis patients. From 1970 and onwards 23 HBV carriers were found, but no new cases of hepatitis B occurred during the study period, i.e. from 1980 and onwards. Only one of the carriers was alive by the end of 2001. In four patients liver disease (in one of them liver cirrhosis) may have been a concomitant cause of death. The antibody response to hepatitis B vaccine was significantly lower in patients than in staff. In four patients a fourth injection was cancelled due to transplantation and bad health, while such data were lacking in 8 cases. In anti-HBs positive patients and controls a significant difference in the response of healthy adults was observed in anti-HBs IgG1 (p < 0.001) vs all other IgG subclasses. Dialysis patients had low levels, or negative findings, in all cases, with IgG1 as the highest proportion found (3/11 patients). An antibody response to pneumococcal vaccination was registered in 25 out of 29 dialysis patients (in all 86%). The IgG-subclass vaccination response to pneumococci in 28 dialysis patients was mainly IgG2 and IgG1 but also occurred in IgG3 and IgG4. Prevaccination antibody levels of the controls were higher in IgG1 and IgG2 (p < 0.01) (n = 21) than in dialysis patients (n = 28). Hepatitis B is nowadays a rare, but still dangerous disease in nephrology units. Dialysis patients have a reduced response to hepatitis B vaccine and vaccination schedules should be started early as some patients otherwise may not receive a fourth injection. The adequate antibody response to pneumococcal vaccination mainly due to IgG2 and IgG1 antibodies indicates that the antigen involved is important in vaccination responses in dialysis patients.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Almroth, Per, et al.
(author)
-
Viscoplastic-plastic modelling of IN792
- 2004
-
In: Computational materials science. - : Elsevier BV. - 0927-0256 .- 1879-0801. ; 29:4, s. 437-445
-
Journal article (peer-reviewed)abstract
- At high temperatures metallic materials behave in a viscous manner exemplified by strain rate dependence, stress relaxation and creep deformation. At low temperatures however, these effects are extremely small, and the behaviour is strain rate independent and shows no or very small relaxation effects. Finally there exists an intermediate region, in which the material behaviour is close to strain rate independent for high strain rates but at the same time shows time dependent inelastic effects, such as stress relaxation and creep. For IN792 this occurs at temperatures around 650 °C. The article describes the extension of a power-law viscoplastic model describing the behaviour of IN792 at 850 °C, also to describe the behaviour at 650 °C, by bounding the elastic-viscoplastic stress-space by a plastic yield surface. The model parameters have been estimated using data from creep test and tailored step relaxation tests, and the model fits well to both the step relaxation data aimed at resembling relevant component conditions and long term creep data. © 2003 Published by Elsevier B.V.
|
|
| 5. |
|
|
